Skip to main content
Caplight Logo









HemostOD SA

HemostOD SA

Private
Saint-SulpiceHealthcare & Life Scienceshttps://www.hemostod.com/

Last Round

Grant

Feb 3, 2026

Total Funding Raised

$10.64M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

HemostOD SA is a biotechnology company that develops a proprietary platform for the ex vivo manufacturing of donor-free, universal human blood platelets for transfusion and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

platelet manufacturingex vivo blood plateletslab-grown bloodbioreactor platformuniversal plateletsCAR-PLTtargeted cargo deliverythrombocytopenia treatmentplatelet lysatesynthetic bloodstem cell engineeringtransfusion medicinebiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HemostOD SA Comparables

Compare HemostOD SA with similar companies based on industry and business-model similarity.

HemostOD SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HemaCell (Xueji Bio)
79%
DewCell Inc.
78%
Sysmex Corporation
75%

HemostOD SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 3, 2026
SeedOct 1, 2025
DebtJun 11, 2024
DebtMay 3, 2022
SeedSep 7, 2021
Accelerator
Apr 29, 2021

Key People

Founding team and executive leadership

Faouzi Khechana

Co-Founder and CEO at HemostOD

Founding Team

Elodie Dahan

CTO

Executive Team

HemostOD SA Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 412% MoM, from 59 to 302.

  • Apr 9, 2026

    Grew 43% QoQ, from 7 to 10 employees.

HemostOD SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HemostOD SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HemostOD SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint-Sulpice
Employee Range12
Year Founded2020
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?